Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2005. Start Trial.
Date Value
December 31, 2025 0.2979M
September 30, 2025 0.2504M
June 30, 2025 0.3253M
March 31, 2025 0.3764M
December 31, 2024 0.3421M
September 30, 2024 0.3915M
June 30, 2024 0.4148M
March 31, 2024 0.3938M
December 31, 2023 0.4359M
September 30, 2023 0.4383M
June 30, 2023 0.4537M
March 31, 2023 0.3943M
December 31, 2022 0.4213M
September 30, 2022 0.3747M
June 30, 2022 0.3763M
March 31, 2022 0.4204M
December 31, 2021 0.353M
September 30, 2021 0.4788M
June 30, 2021 0.4005M
March 31, 2021 0.5554M
December 31, 2020 0.4242M
September 30, 2020 0.2915M
June 30, 2020 0.2575M
March 31, 2020 0.2461M
December 31, 2019 0.5604M
Date Value
September 30, 2019 0.487M
June 30, 2019 0.7367M
March 31, 2019 0.1641M
December 31, 2018 0.246M
September 30, 2018 0.2953M
June 30, 2018 0.4326M
March 31, 2018 0.3983M
December 31, 2017 0.3735M
September 30, 2017 0.6178M
June 30, 2017 0.5266M
March 31, 2017 0.672M
December 31, 2016 0.4968M
September 30, 2016 0.2156M
June 30, 2016 0.2343M
March 31, 2016 0.251M
December 31, 2015 0.4044M
September 30, 2015 0.158M
June 30, 2015 -0.0243M
March 31, 2015 -0.1083M
December 31, 2014 -0.4283M
September 30, 2014 -0.6205M
June 30, 2014 -0.6065M
March 31, 2014 -0.5882M
December 31, 2013 -0.6182M
September 30, 2013 -0.5542M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Windtree Therapeutics, Inc. -11.60M
Biostax Corp. --
Burzynski Research Institute, Inc. -0.0673M
GeneLink, Inc. --
NovAccess Global, Inc. --

Shareholders Equity (Quarterly) Related Metrics